Ixabiso eliphantsi le-COVID-19 Antigen Kit AMDNA08

Iinkcukacha eziKhawulezayo

Le khithi ithatha kuphela imizuzu eyi-15-20 ukufumana iziphumo zovavanyo
Imisebenzi yale khithi ilula kwaye ikhawuleza, kwaye iisampuli kulula ukuzigcina
Le khithi inokugqiba uvavanyo ngaphandle kwee-reagents ezongezelelweyo
Le kit ineempawu zovakalelo oluphezulu kunye nokuchaneka okuphezulu

Ukupakishwa kunye nokuhanjiswa

Iinkcukacha

Ixabiso eliphantsi le-COVID-19 Antigen Kit AMDNA08

Inoveli yeCoronavirus (COVID-19) ye-Antigen Kit AMDNA08 (Latex Immunochromatography)

Ixabiso eliphantsi le-COVID-19 Antigen Kit AMDNA08
Ukusukela oko kwaqhambuka inoveli coronavirus (COVID-19) ekupheleni kuka-2019, abantu abosulelekileyo basasazeke kwihlabathi liphela.Umbutho wezeMpilo weHlabathi (i-WHO) ubhengeze ukuba isifo esibangelwa yile ntsholongwane sabizwa ngokusemthethweni ngokuba yi-COVID-19, kwaye iKomishoni yeHlabathi yoHlelo lweeVirus (ICTV) yabhengeza ngokusesikweni le coronavirus entsha.Ebizwa ngokuba yi-SARS-CoV-2, ekwabizwa ngokuba yi-2019-nCoV, i-SARS-CoV-2 yeyeqela le-β-coronavirus.

Eyona nto isebenzayo ye-receptor ye-SARS-CoV-2 yi-ACE2, kwaye okona kubaluleke kakhulu, i-SARS-CoV-2 Ukukwazi ukudibanisa ne-ACE2 kuphezulu kakhulu kunentsholongwane ye-SARS, okwenza i-SARS-CoV-2 ifumane isakhono esomeleleyo sosulelo, oluthi luvavanyo oluqatha lothintelo kunye nolawulo lobhubhane kunye nonyango lwezonyango.

Ixabiso leKiti yeAntigen ye-COVID-19 ye-AMDNA08 ineengenelo ezicacileyo kubuntununtunu kwaye yindlela eqhelekileyo yokufumanisa iikoronavirus ezintsha.Ukujongana nemeko yangoku yosulelo oluphezulu kunye namanani amaninzi abantu abosulelekileyo, ukufumanisa ngokuchanekileyo nangokukhawuleza kuya kunceda ukuthintela ubhubhane kunye nokulawula kunye nonyango lwezonyango.

Inoveli coronavirus (COVID-19) ikhithi yokufumanisa i-antigen i-AMDNA08 likhadi lovavanyo lwe-in vitro lokumisela inoveli coronavirus kwiisampulu zeswab zenasopharyngeal (NP).Le khithi ifezekisa injongo yokubhaqwa ngokudibanisa inoveli coronavirus (COVID-19) antigen kunye noveli coronavirus (COVID-19) amajoni omzimba ukwenza reaction complex unikezelo ngemibala.Le mveliso inokufumanisa ngokukhawuleza nangokuchanekileyo inoveli coronavirus (COVID-19).

I-COVID-19 Antigen Kit yokuFumana i-AMDNA08 i-Advantage
1. Le khithi ithatha kuphela imizuzu eli-15-20 ukufumana iziphumo zovavanyo.
2. Imisebenzi yale khithi ilula kwaye ikhawuleza, kwaye iisampuli kulula ukuzigcina.
3. Le khithi inokugqiba uvavanyo ngaphandle kwee-reagents ezongezelelweyo.
4. Le kit ineempawu zobuntununtunu obuphezulu kunye nokuchaneka okuphezulu.
5. Yenza ixesha lefestile ye-7-14 yeentsuku zokufunyanwa kwe-antibody entsha

I-COVID-19 Antigen Detection Kit AMDNA08 Ukusebenza kwemveliso
1. Izinga elincomekayo lokuzenzekela: Uvavanyo 5 lwenoveli coronavirus (COVID-19) recombinant antigen imathiriyeli (P1~P5), kwaye iziphumo kufuneka zonke zibe ntle.
2. Ireyithi engalunganga yeziganeko: iikopi ezi-5 zenoveli yekoronavirus (COVID-19) irecombinant antigen reference (N1~N5) ziye zavavanywa, kwaye iziphumo zifanele ukuba azinayo.
3. Ubuncinane bomda wokubhaqwa: iikopi ezi-3 zenoveli coronavirus (COVID-19) recombinant antigen reference (L1~L3) kufuneka zivavanywe, i-L1 ifanele ibe negative, i-L2 kunye ne-L3 mayibe ntle.
4. Ukuphinda-phinda: Phinda uvavanyo lwenoveli coronavirus (COVID-19) recombinant antigen reference (R) amaxesha ali-10, kwaye zonke iziphumo kufuneka zibe ntle.